Catyalyst Pharmaceutical Partners (CPRX) Posts Q4 Loss of 10c/Share

Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q4 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA Securities Reiterates Buy Rating on NVIDIA (NVDA)
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance